Naomi Van Hest
Bristol, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Enhancing economic modelling in obesity: integrating novel type 2 diabetes progression & obstructive sleep apnea remission - a UK case study.
Journal: Journal of medical economics
Published: April 23, 2026
Cost-effectiveness of tirzepatide versus semaglutide for patients with obesity or overweight in the US: evidence from the SURMOUNT-5 head-to-head phase-3 trial.
Journal: Journal of medical economics
Published: April 21, 2026
Cost-Effectiveness of a Digital Leakage Notification System (Heylo™) for People with Ileostomies or Colostomies in the United Kingdom.
Journal: PharmacoEconomics
Published: April 06, 2025
Cost-Effectiveness of Tirzepatide Versus Liraglutide, Both Adjunct to Diet and Exercise, for Patients with Obesity or Overweight: A UK Perspective.
Journal: Advances in therapy
Published: March 05, 2025
Health-care resource use among patients who use illicit opioids in England, 2010-20: A descriptive matched cohort study.
Journal: Addiction (Abingdon, England)
Published: February 25, 2023
Use of Minimal Residual Disease Status to Reduce Uncertainty in Estimating Long-term Survival Outcomes for Newly Diagnosed Multiple Myeloma Patients.
Journal: Journal of health economics and outcomes research
Published: November 21, 2022
Healthcare resource use and associated costs for patients with an ileostomy experiencing peristomal skin complications.
Journal: International wound journal
Published: November 21, 2022
Causes of death among people who used illicit opioids in England, 2001-18: a matched cohort study.
Journal: The Lancet. Public health
Published: August 09, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026